Compare SYRE & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYRE | HII |
|---|---|---|
| Founded | 2013 | 1886 |
| Country | United States | United States |
| Employees | N/A | 44000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 10.1B |
| IPO Year | 2015 | 2010 |
| Metric | SYRE | HII |
|---|---|---|
| Price | $96.64 | $289.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 12 |
| Target Price | $122.53 | ★ $362.58 |
| AVG Volume (30 Days) | ★ 1.1M | 570.9K |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | N/A | ★ 10.24 |
| EPS | N/A | ★ 14.53 |
| Revenue | N/A | ★ $12,484,000,000.00 |
| Revenue This Year | N/A | $8.01 |
| Revenue Next Year | N/A | $6.98 |
| P/E Ratio | ★ N/A | $20.92 |
| Revenue Growth | N/A | ★ 8.23 |
| 52 Week Low | $21.15 | $255.36 |
| 52 Week High | $110.18 | $460.00 |
| Indicator | SYRE | HII |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 62.06 |
| Support Level | $93.45 | $281.35 |
| Resistance Level | $105.09 | $337.15 |
| Average True Range (ATR) | 4.29 | 9.20 |
| MACD | 1.22 | 4.70 |
| Stochastic Oscillator | 93.81 | 60.84 |
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.